Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × cabozantinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 14 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Osteosarcoma 3 Melanoma 3 Clear-cell metastatic renal cell carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Brain Neoplasms 2 Adrenocortical Carcinoma 2 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Kaposi 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1

Interventions

Dexamethasone 56 Lenalidomide 36 daratumumab 34 Bortezomib 26 pomalidomide 22 carfilzomib 20 Cyclophosphamide 20 Calcium Dobesilate 20 Biopsy 18 Specimen Handling 17 Magnetic Resonance Spectroscopy 15 talquetamab 14 fludarabine 13 iberdomide 11 dexamethasone acetate 9 dexamethasone 21-phosphate 9 auricularum 9 selinexor 8 isatuximab 8 trametinib 6 fludarabine phosphate 6 tocilizumab 4 dabrafenib 4 belantamab mafodotin 4 nirogacestat 3 elotuzumab 3 X-Rays 3 Whole-Body Irradiation 3 Sunitinib 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡